AD carriers of H63D mutation in the HFE exhibited increased levels of iron and decreased levels of transferrin and ceruloplasmin, resembling hemochromatosis, which was not found in H63D non-carrier AD patients, suggesting that carrying the H63D mutation seems not to be itself sufficient to increase the risk of AD. This evidence concerns the gene TF and Alzheimer disease.